Brief: Clinuvel Pharmaceuticals Announces Philippe Wolgen Resumes Duties As CEO
30/09/2025 23:34
Oct 1 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX: ANNOUNCES PHILIPPE WOLGEN RESUMES DUTIES AS CEO Further company coverage: CUV.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clinuvel Pharmaceuticals
See all newsBrief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For EPP In Canada
Australia's Clinuvel Pharmaceuticals rises on Canada nod for phototoxicity prevention drug
Brief: Clinuvel Pharmaceuticals Updates On Level II ADR Upgrade, Nasdaq Uplist